Seminars in Nephrology
Volume 24, Issue 5 , Pages 431-436, September 2004

Inflammation: Cause of vascular disease and malnutrition in dialysis patients

  • George A. Kaysen

      Affiliations

    • Division of Nephrology, Department of Medicine University of California Davis, Davis, CA, USA
    • Department of Veteran’s Affairs Northern California Health Care System, Mather, CA, USA
    • Corresponding Author InformationAddress reprint requests to George A. Kaysen, MD, PhD, Chief, Division of Nephrology, University of California Davis, TB 136, Davis, CA 95616

Inflammation occurs in response to tissue injury or the presence of foreign antigens and is important in the mobilization of specific immunologic and nonimmunologic defenses against injury. The vascular endothelium is altered to allow immune competent cells to access the interstitial space. Muscle and visceral proteins are catabolized and the amino acids are used either to supply energy or as substrates for the production of acute-phase proteins that play a role in defense. Restoration of muscle mass is impaired while inflammation is on going. Lipids are mobilized. Although serving a vital role in allowing host survival from acute injury or infection, if unimpeded, or if triggered inappropriately, the acute-phase response may instead lead to increased vascular injury and progressive loss of muscle and visceral protein pools causing malnutrition. Markers of inflammation (C reactive protein [CRP] or interleukin-6 [IL-6] levels) are associated with cardiovascular risk in the general population and in dialysis patients. Hypoalbuminemia also is associated with cardiovascular risk in dialysis patients. Although albumin is considered a marker of nutrition, changes in albumin levels are associated with increased levels of acute-phase proteins. Persistent changes in albumin levels are caused by reduced albumin synthesis associated with inflammation and not decreased normalized protein catabolic rate. The cause(s) of inflammation must be identified and treated to resolve malnutrition and reduce cardiovascular risk.

Keywords:  C-reactive protein , serum amyloid A , cytokines , endothelium , HDL

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by the research service of the United States Department of Veterans Affairs, in part by a grant from the National Institutes of Health RO1 DK 50777, and in part by a gift from Dialysis Clinics Incorporated, Nashville, TN.

PII: S0270-9295(04)00092-0

doi:10.1016/j.semnephrol.2004.06.009

Seminars in Nephrology
Volume 24, Issue 5 , Pages 431-436, September 2004